Abstract
Autosomal dominant retinitis pigmentosa (adRP) is mainly caused by mutations responsible for rhodopsin (RHO) misfolding. Although it was previously proved that unfolded RHO is retained into the endoplasmatic reticulum (ER) eliciting ER-stress, consequent mechanisms underlying photoreceptor degeneration need to be further clarified. Several animal models of RHO mutants have been developed for this purpose and for development of neuroprotective treatments. Here, we compared two of the most used models of adRP, the P23H mutant RHO transgenic and knock-in mouse models, in order to define which are their limits and potentials. Although they were largely used, the differences on the activation of the cell death pathways occurring in these two models still remain to be fully characterized. We present data proving that activation of calpains is a mechanism of cell death shared by both models and that molecules targeting calpains are neuroprotective. Conversely, the role of ER-stress contribution to cell death appears to be divergent and remains controversial.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Behnen P, Felline A, Comitato A et al (2018) A small chaperone improves folding and routing of rhodopsin mutants linked to inherited blindness. iScience 4:1–19
Boyce M, Bryant KF, Jousse C et al (2005) A selective inhibitor of eIF2α dephosphorylation protects cells from ER stress. Science 307:935–939
Chiang W-C, Kroeger H, Sakami S et al (2015) Robust endoplasmic reticulum-associated degradation of rhodopsin precedes retinal degeneration. Mol Neurobiol 52:679–695
Comitato A, Sanges D, Rossi A et al (2014) Activation of Bax in three models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 55:3555–3561
Comitato A, Di Salvo MT, Turchiano G et al (2016) Dominant and recessive mutations in rhodopsin activate different cell death pathways. Hum Mol Genet 25:2801–2812
Griciuc A, Aron L, Piccoli G et al (2010) Clearance of Rhodopsin (P23H) aggregates requires the ERAD effector VCP. Biochim Biophys Acta 1803:424–434
Latella MC, Di Salvo MT, Cocchiarella F et al (2016) In vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina. Mol Ther Nucleic Acids 5:e389
Olsson JE, Gordon JW, Pawlyk BS et al (1992) Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron 9:815–830
Paquet-Durand F, Sanges D, McCall J et al (2010) Photoreceptor rescue and toxicity induced by different calpain inhibitors. J Neurochem 115:930–940
Sakami S, Maeda T, Bereta G et al (2011) Probing mechanisms of photoreceptor degeneration in a new mouse model of the common form of autosomal dominant retinitis pigmentosa due to P23H opsin mutations. J Biol Chem 286:10551–10567
Sanges D, Comitato A, Tammaro R et al (2006) Apoptosis in retinal degeneration involves cross-talk between apoptosis-inducing factor (AIF) and caspase-12 and is blocked by calpain inhibitors. Proc Natl Acad Sci U S A 103:17366–17371
Vighi E, Trifunović D, Veiga-Crespo P et al (2018) Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration. Proc Natl Acad Sci U S A 115:E2997–E3006
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this paper
Cite this paper
Comitato, A., Schiroli, D., La Marca, C., Marigo, V. (2019). Differential Contribution of Calcium-Activated Proteases and ER-Stress in Three Mouse Models of Retinitis Pigmentosa Expressing P23H Mutant RHO. In: Bowes Rickman, C., Grimm, C., Anderson, R., Ash, J., LaVail, M., Hollyfield, J. (eds) Retinal Degenerative Diseases. Advances in Experimental Medicine and Biology, vol 1185. Springer, Cham. https://doi.org/10.1007/978-3-030-27378-1_51
Download citation
DOI: https://doi.org/10.1007/978-3-030-27378-1_51
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-27377-4
Online ISBN: 978-3-030-27378-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)